Phase II randomized study of pembrolizumab with or witho

Project: Research project

Project Details

Description

Phase II randomized study of pembrolizumab with or without epigenetic modulation with CC-486 in patients with platinum-resistant epithelial ovarian, fallopian tube or primary peritoneal cancer
StatusActive
Effective start/end date12/1/1610/30/21

Funding

  • TRANSLATIONAL RESEARCH IN ONCOLOGY

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.